Copied
 
 
2023, DKK
15.03.2024
Bruttoresultat

7.061'

Primær drift

1.131'

Årets resultat

879'

Aktiver

3.153'

Kortfristede aktiver

3.043'

Egenkapital

1.997'

Afkastningsgrad

36 %

Soliditetsgrad

63 %

Likviditetsgrad

+500%

Resultat
15.03.2024
Årsrapport
2023
15.03.2024
2022
21.03.2023
2021
08.04.2022
2020
05.03.2021
2019
18.03.2020
2018
28.05.2019
2017
02.07.2018
Nettoomsætning
Bruttoresultat7.060.8425.804.6194.849.9164.208.6913.964.7333.474.725-7.500
Resultat af primær drift1.131.231474.341439.738370.797406.780332.408-7.500
Indtægter af kapitalandele (tilknyttede og associerede) 0000000
Finansielle indtægter0000000
Finansieringsomkostninger-2.905-16.717-10.4200000
Andre finansielle omkostninger000-13.366-9.627-3.1690
Resultat før skat1.128.326457.624429.318357.431398.220332.460-7.500
Resultat879.251350.802115.918202.961214.716190.671-7.500
Forslag til udbytte0000000
Aktiver
15.03.2024
Årsrapport
2023
15.03.2024
2022
21.03.2023
2021
08.04.2022
2020
05.03.2021
2019
18.03.2020
2018
28.05.2019
2017
02.07.2018
Kortfristede varebeholdninger0000000
Kortfristede tilgodehavender fra salg og tjenesteydelser 2.598.2601.243.5431.593.6201.368.5311.705.3211.402.8140
Likvider444.317564.065604.978643.4381.414.185879.53950.000
Kortfristede aktiver3.042.5771.807.6082.198.5982.011.9693.119.5062.282.35350.000
Immaterielle aktiver og goodwill0000000
Finansielle anlægsaktiver110.496106.25000000
Materielle aktiver0005.59016.77127.9520
Langfristede aktiver110.496106.25005.59016.77127.9520
Aktiver3.153.0731.913.8582.198.5982.017.5593.136.2772.310.30550.000
Aktiver
15.03.2024
Passiver
15.03.2024
Årsrapport
2023
15.03.2024
2022
21.03.2023
2021
08.04.2022
2020
05.03.2021
2019
18.03.2020
2018
28.05.2019
2017
02.07.2018
Forslag til udbytte0000000
Egenkapital1.996.8191.117.568766.766650.848447.887233.17142.500
Hensatte forpligtelser569.925411.500460.000302.0000300.1150
Langfristet gæld til banker0000000
Anden langfristet gæld00000
Leverandører af varer og tjenesteydelser217.960143.142199.86623.612217.05939.6540
Kortfristede forpligtelser586.329384.790971.8321.064.7112.386.7921.777.0197.500
Gældsforpligtelser586.329384.790971.8321.064.7112.386.7921.777.0197.500
Forpligtelser586.329384.790971.8321.064.7112.386.7921.777.0197.500
Passiver3.153.0731.913.8582.198.5982.017.5593.136.2772.310.30550.000
Passiver
15.03.2024
Nøgletal
15.03.2024
Årsrapport
2023
15.03.2024
2022
21.03.2023
2021
08.04.2022
2020
05.03.2021
2019
18.03.2020
2018
28.05.2019
2017
02.07.2018
Afkastningsgrad 35,9 %24,8 %20,0 %18,4 %13,0 %14,4 %-15,0 %
Dækningsgrad Na.Na.Na.Na.Na.Na.Na.
Resultatgrad Na.Na.Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.Na.Na.
Egenkapitals-forretning 44,0 %31,4 %15,1 %31,2 %47,9 %81,8 %-17,6 %
Payout-ratio Na.Na.Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal 38.940,8 %2.837,5 %4.220,1 %Na.Na.Na.Na.
Soliditestgrad 63,3 %58,4 %34,9 %32,3 %14,3 %10,1 %85,0 %
Likviditetsgrad 518,9 %469,8 %226,2 %189,0 %130,7 %128,4 %666,7 %
Resultat
15.03.2024
Gæld
15.03.2024
Årsrapport
15.03.2024
Nyeste:01.01.2023- 31.12.2023(offentliggjort: 15.03.2024)
Information om virksomhedens regnskabsklasse:The annual report of MEDICE Nordic Denmark ApS for 2023 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B, with the adoption of individual rules from class C.
Oplysning om pantsætninger og sikkerhedsstillelser:6. Collaterals and securities No securities or mortgages exist at the balance sheet date.
Beretning
15.03.2024
Dato for ledelsens godkendelse af årsrapporten:2024-02-26
Ledelsespåtegning: Today, Management has considered and adopted the Annual Report of MEDICE Nordic Denmark ApS for the financial year 1 January 2023 - 31 December 2023. The Annual Report is presented in accordance with the Danish Financial Statements Act. In our opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 December 2023 and of the results of the Company's operations for the financial year 1 January 2023 - 31 December 2023. In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review. We recommend that the Annual Report be adopted at the Annual General Meeting. Sorø, 26 February 2024 Executive Board Richard Markus Ammer Direktør
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:Today, Management has considered and adopted the Annual Report of MEDICE Nordic Denmark ApS for the financial year 1 January 2023 - 31 December 2023.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:The Company's principal activities The Company's principal activities consist in doing business in association with counselling, sales promotion, marketing and advertising of pharmaceutical products.